Take advantage of Signant SmartSignals – a suite of comprehensive clinical research solutions – to optimize generalized anxiety disorder (GAD) trials. We pair proven technology solutions with scientific and operational services to improve trial participation and conduct.

Here are a few ways our solutions support sponsors and CROs running GAD trials:

• Make it easier for participants to comprehend study information and consent remotely
• Simplify patient-reported outcome assessments to better evaluate treatment risk-benefit profiles
• Monitor study data as they flow in for data quality concerns
• Guide study decisions to maximize signal detection opportunities

Learn how by downloading the brochure.